China Pharma (CPHI) Revenue (2010 - 2026)
China Pharma (CPHI) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM China Pharma (CPHI) revenue is $4M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
China Pharma (CPHI) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -6.76% |
| 3 Years TTM | -22.10% |
| 5 Years TTM | -18.98% |
| 10 Years TTM | -14.10% |
| All Time TTM | -18.15% |
Annual Revenue change of China Pharma (CPHI)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $980K | -76.33% |
| 2025 | $4.14M | -8.61% |
| 2024 | $4.53M | -35.38% |
| 2023 | $7.01M | -13.46% |
| 2022 | $8.10M | -15.98% |
| 2021 | $9.64M | -11.32% |
| 2020 | $11M | -0.46% |
| 2019 | $11M | -11.44% |
| 2018 | $12M | -6.66% |
| 2017 | $13M | -15.16% |
| 2016 | $16M | -23.49% |
| 2015 | $20M | -8.04% |
| 2014 | $22M | -32.55% |
| 2013 | $33M | -39.81% |
| 2012 | $55M | -32.84% |
| 2011 | $81M | +9.11% |
| 2010 | $74M | N/A |
Comparison China Pharma (CPHI) five years revenue CAGR with competitors
China Pharma (CPHI) five years revenue CAGR is -19.02%.